ACADIA Pharmaceuticals Inc.

Q4 2019 13F Holders

Symbol
ACAD
CUSIP
004225108
Type
Equity
Class
COM
Num filings
303
Total reported value, excl. options
$6.48 B
Manager Report Date Value ($000) Shares Option Type